Aleš Tomek

1.7k total citations
85 papers, 770 citations indexed

About

Aleš Tomek is a scholar working on Epidemiology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Aleš Tomek has authored 85 papers receiving a total of 770 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 22 papers in Cardiology and Cardiovascular Medicine and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Aleš Tomek's work include Acute Ischemic Stroke Management (19 papers), Venous Thromboembolism Diagnosis and Management (15 papers) and Antiplatelet Therapy and Cardiovascular Diseases (11 papers). Aleš Tomek is often cited by papers focused on Acute Ischemic Stroke Management (19 papers), Venous Thromboembolism Diagnosis and Management (15 papers) and Antiplatelet Therapy and Cardiovascular Diseases (11 papers). Aleš Tomek collaborates with scholars based in Czechia, United States and Switzerland. Aleš Tomek's co-authors include A. Jaggy, M. Vandevelde, Marcus G. Doherr, Franck Forterre, Jakub Hort, Sigitas Čižinauskas, Martin Šrámek, Jan Pícha, Victor L. Serebruany and James J. DiNicolantonio and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Stroke.

In The Last Decade

Aleš Tomek

76 papers receiving 729 citations

Peers

Aleš Tomek

PRM

EPIDE

SURGE

CCM

NEURO

Gürsel Yılmaz Türkiye

R Schneider Germany

Minsu Kim South Korea

Takumi Aramaki Japan

Sheng‐Nan Chang Taiwan

Ya-Hui Lin China

Ye Yuan China

V. Swetha E. Jeganathan United States

Zhiming Sun China

Gürsel Yılmaz Türkiye

Aleš Tomek

209 ×1.1

PRM

197 ×1.3

EPIDE

159 ×1.1

SURGE

28 ×0.2

CCM

83 ×0.7

NEURO

Citations per year, relative to Aleš Tomek Aleš Tomek (= 1×) peers Gürsel Yılmaz

Countries citing papers authored by Aleš Tomek

Since Specialization

Citations

This map shows the geographic impact of Aleš Tomek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aleš Tomek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aleš Tomek more than expected).

Fields of papers citing papers by Aleš Tomek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aleš Tomek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aleš Tomek. The network helps show where Aleš Tomek may publish in the future.

Co-authorship network of co-authors of Aleš Tomek

This figure shows the co-authorship network connecting the top 25 collaborators of Aleš Tomek. A scholar is included among the top collaborators of Aleš Tomek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aleš Tomek. Aleš Tomek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ganesh, Aravind, Ondřej Volný, Aleš Tomek, et al.. (2024). Utilization, Workflow, and Outcomes of Endovascular Thrombectomy in Patients With vs Without Premorbid Disability in a National Registry. Neurology Clinical Practice. 14(6). e200341–e200341. 1 indexed citations

Herzig, Roman, Robert Mikulík, Silvie Bělašková, et al.. (2024). Intravenous Thrombolysis in Posterior versus Anterior Circulation Stroke: Clinical Outcome Differs Only in Patients with Large Vessel Occlusion. Biomedicines. 12(2). 404–404.

Mikulík, Robert, Michal Bar, Silvie Bělašková, et al.. (2022). Ultrashort Door‐to‐Needle Time for Intravenous Thrombolysis Is Safer and Improves Outcome in the Czech Republic: Nationwide Study 2004 to 2019. Journal of the American Heart Association. 11(10). e023524–e023524. 7 indexed citations

Šulc, Vlastimil, Jan Svoboda, Martin Kynčl, et al.. (2022). Evaluation of Blood-Brain Barrier Integrity by the Analysis of Dynamic Contrast-Enhanced MRI – a Comparison of Quantitative and Semi-Quantitative Methods. Physiological Research. 71(Suppl. 2). S259–S275. 4 indexed citations

Bryndová, Lucie, Michal Bar, Roman Herzig, et al.. (2021). Concentrating stroke care provision in the Czech Republic: The establishment of Stroke Centres in 2011 has led to improved outcomes. Health Policy. 125(4). 520–525. 12 indexed citations

Mikulík, Robert, Michal Bar, David Černík, et al.. (2021). Stroke 20 20: Implementation goals for intravenous thrombolysis. European Stroke Journal. 6(2). 151–159. 15 indexed citations

Haršány, Michal, Michal Bar, David Černík, et al.. (2021). One-Stop Management to Initiate Thrombolytic Treatment on the Computed Tomography Table: Adoption and Results. Journal of Stroke. 23(3). 437–439. 2 indexed citations

Šrámek, Martin, T Honĕk, Aleš Tomek, et al.. (2021). Screening and Risk Stratification Strategy Reduced Decompression Sickness Occurrence in Divers With Patent Foramen Ovale. JACC. Cardiovascular imaging. 15(2). 181–189. 12 indexed citations

Šaňák, Daniel, Stanislava Jakubíček, David Černík, et al.. (2018). Intravenous Thrombolysis in Patients with Acute Ischemic Stroke after a Reversal of Dabigatran Anticoagulation with Idarucizumab: A Real-World Clinical Experience. Journal of Stroke and Cerebrovascular Diseases. 27(9). 2479–2483. 22 indexed citations

10.

Meluzínová, Eva, Aleš Tomek, Dana Horáková, et al.. (2017). Myxovirus Resistance Protein A mRNA Expression Kinetics in Multiple Sclerosis Patients Treated with IFNβ. PLoS ONE. 12(1). e0169957–e0169957. 1 indexed citations

11.

Volný, Ondřej, Antonı́n Krajina, Roman Herzig, et al.. (2016). Konsenzus a návrh k algoritmu léčby - mechanická trombektomie uakutního mozkového infarktu : Výsledky intervenčních studií MRCLEAN, ESCAPE, SWIFT PRIME, EXTEND-IA, REVASCAT. Česká a slovenská neurologie a neurochirurgie. 79(1). 1 indexed citations

12.

Tomek, Aleš. (2015). Vaskulitidy centrálního nervového systému. Neurologie pro praxi. 16(6). 334–339. 1 indexed citations

13.

Serebruany, Victor L., et al.. (2015). Among antithrombotic agents, prasugrel, but not ticagrelor, is associated with reduced 30day mortality in patients with ST-elevated myocardial infarction. International Journal of Cardiology. 195. 104–110. 11 indexed citations

14.

Serebruany, Victor L., et al.. (2015). Survival After Solid Cancers in Antithrombotic Trials. The American Journal of Cardiology. 116(6). 969–972. 6 indexed citations

15.

Tomek, Aleš, et al.. (2014). Monitorování účinku nových orálních antikoagulancií. Neurologie pro praxi. 15(3). 131–135. 1 indexed citations

16.

Šrámek, Martin, Luděk Šefc, Jaroslav Januška, et al.. (2014). Effect of Catheter-Based Patent Foramen Ovale Closure on the Occurrence of Arterial Bubbles in Scuba Divers. JACC: Cardiovascular Interventions. 7(4). 403–408. 37 indexed citations

17.

Tomek, Aleš, et al.. (2013). Construction Industry Products Diversification by Implementation of BIM. SHILAP Revista de lepidopterología. 6 indexed citations

18.

Knotek, Z., et al.. (2011). Hepatocellular carcinoma in a green iguana – a case study. Acta Veterinaria Brno. 80(3). 243–247. 13 indexed citations

19.

Lang, Johann, et al.. (2007). Lumbar Spinal ‘Juxtaarticular’ Cyst in a Gordon Setter. Journal of Veterinary Medicine Series A. 54(9). 494–498. 5 indexed citations

20.

Honĕk, T, Josef Veselka, Aleš Tomek, et al.. (2006). Foramen ovale patens jako příčina paradoxní embolizace u sportovních potápěčů. Cor et Vasa. 48. 286–288. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact